NCT05521542View on ClinicalTrials.gov

Advanced NanoTherapies Dual-API DCB to Treat De-Novo Lesions in Patients With Symptomatic Coronary Artery Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 30, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2027

Conditions
Coronary Artery Disease
Interventions
DEVICE

SirPlux Duo™ Dual-API Coated PTCA Balloon Catheter

SirPlux Duo™ Dual-API Coated PTCA Balloon Catheter is a Drug-Coated Balloon to treat de novo lesions in patients with symptomatic stable angina, unstable angina, or NSTEMI

Trial Locations (5)

3168

Victorian Heart Institute - Monash University, Clayton

4032

The Prince Charles Hospital, Chermside

50000

Royal Adelaide Hospital, Adelaide

Unknown

Cecanot Hospital, Santo Domingo

Te Toka Tumai Auckland, Auckland City Hospital, Auckland

Sponsors
All Listed Sponsors
collaborator

Monash University

OTHER

collaborator

Cardiovascular Research Foundation, New York

OTHER

lead

Advanced NanoTherapies

INDUSTRY

NCT05521542 - Advanced NanoTherapies Dual-API DCB to Treat De-Novo Lesions in Patients With Symptomatic Coronary Artery Disease | Biotech Hunter | Biotech Hunter